Atlas Trials

Evaluate the Effects of Dapagliflozin in Patients With Type 2 Diabetes

Clinical trial NCT03269058 · COMPLETED

Trial details

NCT number
NCT03269058
Sponsor
Centre Hospitalier Universitaire Dijon
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Type-2 DiabetesOral Antidiabetics
Start date
2017-12-20
Primary completion
2021-05-06
Enrollment
28

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.